1. Home
  2. GLUE vs TITN Comparison

GLUE vs TITN Comparison

Compare GLUE & TITN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLUE
  • TITN
  • Stock Information
  • Founded
  • GLUE 2019
  • TITN 1980
  • Country
  • GLUE United States
  • TITN United States
  • Employees
  • GLUE N/A
  • TITN N/A
  • Industry
  • GLUE Biotechnology: Pharmaceutical Preparations
  • TITN Other Specialty Stores
  • Sector
  • GLUE Health Care
  • TITN Consumer Discretionary
  • Exchange
  • GLUE Nasdaq
  • TITN Nasdaq
  • Market Cap
  • GLUE 351.2M
  • TITN 341.6M
  • IPO Year
  • GLUE 2021
  • TITN 2007
  • Fundamental
  • Price
  • GLUE $4.80
  • TITN $20.00
  • Analyst Decision
  • GLUE Buy
  • TITN Buy
  • Analyst Count
  • GLUE 2
  • TITN 4
  • Target Price
  • GLUE $13.50
  • TITN $22.25
  • AVG Volume (30 Days)
  • GLUE 369.2K
  • TITN 150.1K
  • Earning Date
  • GLUE 08-07-2025
  • TITN 08-28-2025
  • Dividend Yield
  • GLUE N/A
  • TITN N/A
  • EPS Growth
  • GLUE N/A
  • TITN N/A
  • EPS
  • GLUE 0.29
  • TITN N/A
  • Revenue
  • GLUE $177,986,000.00
  • TITN $2,580,509,000.00
  • Revenue This Year
  • GLUE $83.76
  • TITN N/A
  • Revenue Next Year
  • GLUE N/A
  • TITN $0.57
  • P/E Ratio
  • GLUE $16.32
  • TITN N/A
  • Revenue Growth
  • GLUE 2990.57
  • TITN N/A
  • 52 Week Low
  • GLUE $3.50
  • TITN $12.50
  • 52 Week High
  • GLUE $12.40
  • TITN $23.41
  • Technical
  • Relative Strength Index (RSI)
  • GLUE 51.69
  • TITN 51.37
  • Support Level
  • GLUE $4.54
  • TITN $18.86
  • Resistance Level
  • GLUE $4.93
  • TITN $21.57
  • Average True Range (ATR)
  • GLUE 0.21
  • TITN 0.77
  • MACD
  • GLUE 0.06
  • TITN 0.06
  • Stochastic Oscillator
  • GLUE 81.43
  • TITN 42.07

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

About TITN Titan Machinery Inc.

Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.

Share on Social Networks: